Bioherent
PrivateLast Round
Early Funding
Jul 17, 2025
Total Funding Raised
$5.59M
Company Overview
Bioherent operates in Healthcare & Life Sciences and is based in Málaga. Its latest recorded funding round was an Early Funding round in July 2025.
Bioherent is a deep-tech company that develops next-generation in-vitro diagnostic (IVD) solutions using silicon photonics and proprietary surface chemistry for drug allergy testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioherent Comparables
Compare Bioherent with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allergios | 83% | |
| Eroica Dx | 75% | |
| Genalyte | 69% |
For institutional investors. Book with your work email.
Bioherent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 17, 2025 | ||||
| Seed | Feb 25, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bioherent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDTI Innvierte | Early Funding |
| Axon Partners Group | Early Funding |
| Center for Technological Development and Innovation | Seed |
| Bullnet Capital | Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 2823% MoM, from 30 to 877.
- Nov 7, 2025
Monthly visitors grew 95% MoM.
For institutional investors. Book with your work email.
Bioherent Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bioherent's valuation, stock price, and market status.
Is Bioherent a public or private company?
Bioherent is a private company.
What is the current stock price of Bioherent?
Bioherent is a private company, so its shares have no public market price. Caplight tracks Bioherent's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bioherent worth (valuation)?
Valuation information for Bioherent is not publicly available.
Can I buy Bioherent stock?
Bioherent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bioherent's last funding round?
Bioherent's most recent funding round was Early Funding on July 17, 2025.
Who are the main investors in Bioherent?
Key investors in Bioherent include Bullnet Capital.
Will Bioherent IPO soon?
No public IPO plans have been announced for Bioherent.
How can I track Bioherent secondary market activity?
Caplight tracks bids, offers, and trades in Bioherent's shares on secondary markets.